High Dose GT-02287

Drug identity checked against registry records

Also recorded as GT-02287 800 or 1000 mg/day

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's DiseaseNCT07280299GANXPhase 2Not yet recruiting2028-06-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.